Global Virtual Clinical Trials Market (2021 to 2026) - Growth, Trends, Covid-19 Impact, and Forecasts
October 07, 2021 04:43 ET
|
Research and Markets
Dublin, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute
September 22, 2021 08:00 ET
|
American Oncology Network
Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner...
Global $35 Billion Clinical Trials Support Services Markets to 2028 - Increasing Number Of CROs Providing Services
September 21, 2021 06:13 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Support Services Market Size, Share & Trends Analysis Report by Phase, by Service (IRB, Clinical Trial Site Management,...
Prelude Dynamics Announces Acquisition by Canela Capital
September 17, 2021 11:35 ET
|
Prelude Dynamics
AUSTIN, Texas, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Prelude Dynamics, the leading eClinical technology company for animal and human health researchers, announced today that it has been acquired by...
MAKO Medical Announces Partnership with Robert C. Byrd Clinic Located at the West Virginia School of Osteopathic Medicine
September 09, 2021 06:37 ET
|
MAKO Medical
Lewisburg, West Virginia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, announced a comprehensive partnership with the...
Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic Cancer
September 08, 2021 09:00 ET
|
XBiotech Inc.
AUSTIN, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced that Benjamin Musher M.D., will chair XBiotech’s clinical program for pancreatic cancer....
The Worldwide High Content Screening/Imaging Industry Should Reach $2.3 Billion by 2026
September 03, 2021 06:13 ET
|
Research and Markets
Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "High Content Screening/Imaging: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global...
Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
September 02, 2021 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director
August 30, 2021 09:00 ET
|
XBiotech Inc.
AUSTIN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced the addition of Mark Ziats, M.D. Ph.D. as Medical Director. Dr. Ziats will be involved in...
Global Biotechnology Services Market Opportunities and Strategies to 2030
August 30, 2021 07:13 ET
|
Research and Markets
Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "Biotechnology Services Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to...